Levocarnitine Use Is Associated With Improvement in Sarcopenia in Patients With Liver Cirrhosis

Although the effect of levocarnitine (L‐carnitine) on hyperammonemia has been reported in patients with liver cirrhosis (LC), its effect on sarcopenia remains to be elucidated. We assessed the effects of L‐carnitine on sarcopenia in patients with LC. We retrospectively evaluated 52 patients with LC...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiramatsu, Akira, Aikata, Hiroshi, Uchikawa, Shinsuke, Ohya, Kazuki, Kodama, Kenichiro, Nishida, Yuno, Daijo, Kana, Osawa, Mitsutaka, Teraoka, Yuji, Honda, Fumi, Inagaki, Yuki, Morio, Kei, Morio, Reona, Fujino, Hatsue, Nakahara, Takashi, Murakami, Eisuke, Yamauchi, Masami, Kawaoka, Tomokazu, Miki, Daiki, Tsuge, Masataka, Imamura, Michio, Tanaka, Junko, Chayama, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396356/
https://www.ncbi.nlm.nih.gov/pubmed/30859147
http://dx.doi.org/10.1002/hep4.1309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396356/
https://www.ncbi.nlm.nih.gov/pubmed/30859147
http://dx.doi.org/10.1002/hep4.1309

Ejemplares similares